Bryan E Roberts
CIK 1239242 · last filed 2023-06-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
TXG price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
2494 SAND HILL ROAD STE 200
MENLO PARK, CA 94025
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TXG | Director | 3,878,925 | $69.75 | $270.56M | -$218.40M | 13 | 2023-06-16 |
| CASTLIGHT HEALTH, INC. (CSLT) Delisted | Director | 0 | $2.05 | $0 | $4.79M | 16 | 2022-02-18 |
| Achaogen, Inc. (AKAO) Delisted | Director | 637,675 | — | — | $0 | 6 | 2018-06-07 |
| Vitae Pharmaceuticals, Inc (VTAE) Delisted | Director | 275,450 | — | — | $6.18M | 4 | 2016-05-27 |
| Zeltiq Aesthetics Inc (ZLTQ) Delisted | Director | 5,786 | — | — | -$3.05M | 11 | 2015-11-04 |
| IRWD | Director | 71,951 | $3.57 | $256.9K | -$13.16M | 35 | 2015-06-16 |
| ATHENAHEALTH INC (ATHN) Delisted | Director | 50 | $9.59 | $480 | -$48.3K | 5 | 2009-05-26 |
| XENOPORT INC (XNPT) Delisted | Director | 20,279 | — | — | -$2.9K | 3 | 2007-06-01 |
| SIRNA THERAPEUTICS INC (RNAI) Delisted | Director | 0 | — | — | $0 | 1 | 2007-01-03 |
Recent Filings · Page 6 of 10
94 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-03-13 | Achaogen, Inc. (AKAO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-03-06 | Zeltiq Aesthetics Inc (ZLTQ) Delisted | Gift (G) | −8,000 | $0 | EDGAR |
| 2014-02-26 | IRWD | Other (J) | −931,248 | $0 | EDGAR |
| 2014-01-27 | Zeltiq Aesthetics Inc (ZLTQ) Delisted | Other (J) | −1,991,920 | $0 | EDGAR |
| 2014-01-27 | IRWD | Other (J) | −931,249 | $0 | EDGAR |
| 2014-01-16 | IRWD | Sell (S) | −21,200 | -$266.5K | EDGAR |
| 2014-01-13 | IRWD | Sell (S) | −823,350 | -$10.47M | EDGAR |
| 2014-01-07 | IRWD | Sell (S) | −55,450 | -$666.0K | EDGAR |
| 2014-01-03 | IRWD | Grant (A) | +9,554 | $2.5K | EDGAR |
| 2013-11-18 | Zeltiq Aesthetics Inc (ZLTQ) Delisted | Sell (S) | −575,000 | -$7.03M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.